$13.04 -0.33 (%) Insmed Inc - NASDAQ

Sep. 16, 2014 | 11:26 AM

Partner Headlines

  1. Markets Rise; Macy's Lowers Comparable Sales Outlook

    Benzinga | Aug. 13, 2014 | 10:59AM EST
  2. Benzinga's Volume Movers

    Benzinga | Aug. 13, 2014 | 10:31AM EST
  3. Dow Breaks Four Day Losing Streak As Calm Restores Last Week's Jittery Market

    Benzinga | Aug. 4, 2014 | 16:57PM EST
  4. Indexes Reverse Losses; Michael Kors Beats Expectations Again

    Benzinga | Aug. 4, 2014 | 15:13PM EST
  5. Alere Drops On Downbeat Results; Trex Shares Surge

    Benzinga | Aug. 4, 2014 | 13:03PM EST
  6. Markets Open Higher; Michael Kors Results Beat Street View

    Benzinga | Aug. 4, 2014 | 11:32AM EST
  7. Morning Market Losers

    Benzinga | Aug. 4, 2014 | 09:54AM EST
  8. Benzinga's Top #PreMarket Losers

    Benzinga | Aug. 4, 2014 | 08:16AM EST
  9. Events Scheduled for Week of Jun 23rd to Jun 27th, 2014

    Benzinga | Jun. 23, 2014 | 18:25PM EST
  10. Mid-Afternoon Market Update: Fed Tapers Another $10B; Will Purchase $15B/Month Of MBS & $20B Per Month Of Treasuries

    Benzinga | Jun. 18, 2014 | 15:39PM EST
  11. Mid-Day Market Update: US Stocks Slide Ahead Of Fed Decision; Adobe Shares Spike Higher

    Benzinga | Jun. 18, 2014 | 12:47PM EST
  12. Mid-Morning Market Update: Markets Mostly Flat; FedEx Results Top Street View

    Benzinga | Jun. 18, 2014 | 10:30AM EST
  13. Benzinga's Volume Movers

    Benzinga | Jun. 18, 2014 | 10:17AM EST
  14. Morning Market Movers

    Benzinga | Jun. 18, 2014 | 09:41AM EST
  15. Insmed Up Over 30% Following FDA Decision

    Benzinga | Jun. 18, 2014 | 08:24AM EST
  16. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 18, 2014 | 08:05AM EST
  17. Insmed Shares Rally Over $14 As Piper Jaffray Boosts Price Target To $51

    Benzinga | Apr. 23, 2014 | 15:49PM EST
  18. Mid-Afternoon Market Update: American Capital Rises as MannKind Shares Take a Hit

    Benzinga | Mar. 31, 2014 | 16:03PM EST
  19. Mid-Day Market Update: Nordion Surges On Acquisition News; BlackBerry Shares Decline

    Benzinga | Mar. 31, 2014 | 12:20PM EST
  20. Insmed falls on mixed results

    IBD | Mar. 26, 2014 | 18:50PM EST
  21. Market Wrap For March 26: Markets Close Near Session Lows In Yet Another Volatile Trading Session

    Benzinga | Mar. 26, 2014 | 16:46PM EST
  22. Insmed Falls On Mixed Results For Lung Drug

    IBD | Mar. 26, 2014 | 12:18PM EST
  23. Morning Market Losers

    Benzinga | Mar. 26, 2014 | 09:53AM EST
  24. Benzinga's Top #PreMarket Losers

    Benzinga | Mar. 26, 2014 | 08:14AM EST
  25. UPDATE: Insmed Says Arikayce Did Not Meet Pre-Specified Level for Statistical Significance

    Benzinga | Mar. 26, 2014 | 07:17AM EST
  26. Benzinga's Top #PreMarket Gainers

    Benzinga | Feb. 18, 2014 | 08:08AM EST
  27. Benzinga's Top #PreMarket Losers

    Benzinga | Feb. 11, 2014 | 08:17AM EST
  28. UPDATE: Piper Jaffray Initiates Coverage on Insmed as 2014 Biotech Sector Outlook Remains Strong

    Benzinga | Nov. 27, 2013 | 10:48AM EST
  29. Market Wrap For Tuesday, October 15: Earnings Reports And White House Progress Send Markets Down

    Benzinga | Oct. 15, 2013 | 16:36PM EST
  30. Mid-Afternoon Market Update: Tumi Holdings Rises Amid Market Decline

    Benzinga | Oct. 15, 2013 | 15:30PM EST
  31. Insmed Reports Issuance of Two Patents

    Benzinga | Sep. 11, 2013 | 07:34AM EST
  32. Leerink Swann Reiterates Outperform on Insmed Following MEDACorp KOL Checks

    Benzinga | Aug. 28, 2013 | 11:52AM EST
  33. Weekly CEO Buys Highlight: TPGI, INSM, EQU, FCEL

    GuruFocus | Jan. 13, 2013 | 12:33PM EST
  34. Insmed Names Lewis CEO

    Benzinga | Sep. 11, 2012 | 02:08AM EST
  35. Insmed Inc. Reports Operating Results (10-Q)

    GuruFocus | Aug. 7, 2012 | 05:19AM EST
  36. Insmed up 12% After Insider Share Purchase

    Benzinga | Jun. 15, 2012 | 08:10AM EST
  37. Insmed Provides Corporate Update; Projects Cash Sufficient to Generate Top-Line Data from Three Priority Studies

    Benzinga | May. 30, 2012 | 02:04AM EST
  38. Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE In Patients With Non-tuberculous Mycobacterial Lung Disease

    Benzinga | May. 23, 2012 | 02:03AM EST
  39. Insmed Skyrockets 70% after FDA Lifts Clinical Hold

    Benzinga | May. 7, 2012 | 04:45AM EST
  40. Benzinga's Microcap Movers for Friday January 20, 2012

    Benzinga | Jan. 22, 2012 | 03:19AM EST
  41. Insmed Surges after Clinical Hold Lifted by FDA

    Benzinga | Jan. 20, 2012 | 02:06AM EST
Trading Center